CTMX : Insider Transactions for Cytomx Therapeutics, Inc.

Company Profile CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	47,819	75,591	103,916	162,805
Total Sell Value	$99,726	$138,068	$174,902	$267,502
Total People Sold	5	5	5	8
Total Sell Transactions	5	10	14	26
End Date	2024-03-03	2023-12-01	2023-06-02	2022-06-02

Adjust Filter Settings

Records found: 286

Page 11 of 12

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Shannon Timothy M

Director

– • –

2016-06-03

$10.83

$199,575

I/I

(18,428)

4,404,306

Canaan Partners Ix Llc

Director

– • •

2016-06-02

$10.79

$444,472

I/I

(41,193)

4,422,734

Shannon Timothy M

Director

– • –

2016-06-02

$10.79

$444,472

I/I

(41,193)

4,422,734

Canaan Partners Ix Llc

Director

– • •

2016-06-01

$10.75

$241,477

I/I

(22,463)

4,463,927

Shannon Timothy M

Director

– • –

2016-06-01

$10.75

$241,477

I/I

(22,463)

4,463,927

Canaan Partners Ix Llc

Director

– • •

2016-05-27

$10.60

$265,869

I/I

(25,082)

4,486,390

Shannon Timothy M

Director

– • –

2016-05-27

$10.60

$265,869

I/I

(25,082)

4,486,390

Canaan Partners Ix Llc

Director

– • •

2016-05-26

$10.43

$416,021

I/I

(39,887)

4,511,472

Shannon Timothy M

Director

– • –

2016-05-26

$10.43

$416,021

I/I

(39,887)

4,511,472

Canaan Partners Ix Llc

Director

– • •

2016-05-25

$10.02

$114,789

I/I

(11,456)

4,551,359

Shannon Timothy M

Director

– • –

2016-05-25

$10.02

$114,789

I/I

(11,456)

4,551,359

Shannon Timothy M

• • –

2016-05-24

$10.00

$12,000

I/I

(1,200)

4,562,815

Canaan Partners Ix Llc

Director

– • •

2016-05-24

$10.00

$12,000

I/I

(1,200)

4,562,815

Shannon Timothy M

• • –

2016-05-23

$10.10

$121,735

I/I

(12,053)

4,564,015

Canaan Partners Ix Llc

Director

– • •

2016-05-23

$10.10

$121,735

I/I

(12,053)

4,564,015

Shannon Timothy M

• • –

2016-05-20

$10.09

$62,427

I/I

(6,187)

4,576,068

Canaan Partners Ix Llc

Director

– • •

2016-05-20

$10.09

$62,427

I/I

(6,187)

4,576,068

Shannon Timothy M

• • –

2016-05-19

$10.14

$25,350

I/I

(2,500)

4,582,255

Canaan Partners Ix Llc

Director

– • •

2016-05-19

$10.14

$25,350

I/I

(2,500)

4,582,255

Goeltz Ii Robert C.

Chief Financial Officer

• • –

2016-05-12

$4.47

$8,946

D/D

2,000

Canaan Partners Ix Llc

Director

– • •

2016-04-25

$0.00

I/I

(300,000)

4,584,755

Gluck Frederick W

• • –

2016-04-05

$0.00

I/I

348,754

22,111

Kavanaugh William Michael

Chief Scientific Officer and

• – –

2015-12-31

$6.61

$58,983

D/D

8,917

13,917

Tepper Robert I

10% Owner

– – •

2015-10-14

$0.00

D/D

8,670,351

Canaan Partners Ix Llc

Director

– • •

2015-10-14

$0.00

I/I

4,884,755

286 Records found	Previous 10 11 12	Page 11 of 12

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: